You are here: Industry Insights > Cellect

News List

Cellect Biotechnology Receives Approval for U.S. Clinical Trial americanpharmaceuticalreview
December 24, 2019
Cellect Biotechnology has received approval to initiate the trial in the U.S. to evaluate the safety and tolerability of the ApoGraft technology for haploidentical bone marrow transplantations.
Cellect Granted Key European Patent for Its Stem Cell Selection Technology biospectrumasia
November 23, 2018
Through negative selection, Cellect's technology identifies mature cells that can be harmful to the recipient and selectively eliminates those cells through apoptosis (cell death).
Cellect receives patent for Stem Cell Selection Technology in Korea biospectrumasia
August 21, 2018
Cellect Biotechnology Ltd., has received a Notice of Allowance from the Korean Intellectual Property Office for its patent.
Cellect, denovoMATRIX start stem cell research project fiercebiotech
July 09, 2018
Cellect Biotechnology and a group at Technische Universität Dresden (TU Dresden) have teamed upto explore the combination of their stem cell technologies.